| Barbara Gina Chrysler, OTR/L, CLT | |
|
6625 Lyndale Ave S Ste 500, Richfield, MN 55423-2691 | |
| (612) 886-3706 | |
| (612) 886-3681 |
| Full Name | Barbara Gina Chrysler |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapy |
| Experience | 25 Years |
| Location | 6625 Lyndale Ave S Ste 500, Richfield, Minnesota |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1568050623 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 102163 (Minnesota) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Fairview Express Care | 3375645179 | 1523 |
News Archive
Researchers at the University of Eastern Finland have discovered new changes occurring in the human brain in the early stages of Alzheimer's disease.
Novozymes Biopharma, part of Novozymes A/S world leader in bioinnovation, today announced that an ophthalmic solution made using its recombinant human albumin, has been approved for Phase I/II development by the FDA.
BioTek announces the launch of Gen5™ 3.0 Data Analysis Software for their imaging and microplate detection instruments.
ChromaDex Corporation, an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, animal health, cosmetic and pharmaceutical industries, announced today the launch of NIAGEN, its novel, patented, branded nicotinamide riboside.
› Verified 8 days ago
| Provider Name | Fairview Express Care |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1053952606 PECOS PAC ID: 3375645179 Enrollment ID: O20081028000548 |
News Archive
Researchers at the University of Eastern Finland have discovered new changes occurring in the human brain in the early stages of Alzheimer's disease.
Novozymes Biopharma, part of Novozymes A/S world leader in bioinnovation, today announced that an ophthalmic solution made using its recombinant human albumin, has been approved for Phase I/II development by the FDA.
BioTek announces the launch of Gen5™ 3.0 Data Analysis Software for their imaging and microplate detection instruments.
ChromaDex Corporation, an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, animal health, cosmetic and pharmaceutical industries, announced today the launch of NIAGEN, its novel, patented, branded nicotinamide riboside.
› Verified 8 days ago
| Provider Name | Stepping Stone Clinic Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1720526759 PECOS PAC ID: 1951675321 Enrollment ID: O20170922003441 |
News Archive
Researchers at the University of Eastern Finland have discovered new changes occurring in the human brain in the early stages of Alzheimer's disease.
Novozymes Biopharma, part of Novozymes A/S world leader in bioinnovation, today announced that an ophthalmic solution made using its recombinant human albumin, has been approved for Phase I/II development by the FDA.
BioTek announces the launch of Gen5™ 3.0 Data Analysis Software for their imaging and microplate detection instruments.
ChromaDex Corporation, an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, animal health, cosmetic and pharmaceutical industries, announced today the launch of NIAGEN, its novel, patented, branded nicotinamide riboside.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Barbara Gina Chrysler, OTR/L, CLT 6305 Peacedale Ave, Edina, MN 55424-1929 Ph: (612) 618-9751 | Barbara Gina Chrysler, OTR/L, CLT 6625 Lyndale Ave S Ste 500, Richfield, MN 55423-2691 Ph: (612) 886-3706 |
News Archive
Researchers at the University of Eastern Finland have discovered new changes occurring in the human brain in the early stages of Alzheimer's disease.
Novozymes Biopharma, part of Novozymes A/S world leader in bioinnovation, today announced that an ophthalmic solution made using its recombinant human albumin, has been approved for Phase I/II development by the FDA.
BioTek announces the launch of Gen5™ 3.0 Data Analysis Software for their imaging and microplate detection instruments.
ChromaDex Corporation, an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, animal health, cosmetic and pharmaceutical industries, announced today the launch of NIAGEN, its novel, patented, branded nicotinamide riboside.
› Verified 8 days ago
Mrs. Courtney Vander Wal, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 6625 Lyndale Ave S, Richfield, MN 55423 Phone: 952-285-2840 | |
Gina Brady, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2400 W 64th St, Richfield, MN 55423 Phone: 612-798-8323 | |
Leah Tacheny, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 7727 Portland Ave, Richfield, MN 55423 Phone: 612-861-1691 | |
Kristin Marie Ries, OTD, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 6625 Lyndale Ave S Ste 430, Richfield, MN 55423 Phone: 952-285-2840 | |
Mrs. Katherine Marie Eiden, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2400 W 64th St, Richfield, MN 55423 Phone: 952-767-5918 | |
Laura Frisby, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 7727 Portland Ave, Richfield, MN 55423 Phone: 612-861-1691 | |
Kiersten Lynn Anderson, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2400 W 64th St, Richfield, MN 55423 Phone: 612-861-1688 |